EyePoint Inc

EyePoint CMO Ribeiro Ramiro Buys 2,437 Shares While Selling Options: A Contrarian Bet on Undervalued Visionary Stock

EyePoint insider moves: CMO Ribeiro Ramiro’s disciplined buying and option selling signals confidence in future clinical milestones, hinting at upside potential for investors.

EyePoint Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

18/02/2026, 22:32

4 minutes to read

EyePoint CEO Buys 20,793 Shares Amid Quiet Volatility, Signaling Quiet Confidence in Future Pipeline

CEO insider buying at EyePoint signals long‑term confidence—discover what this move means for investors amid market volatility.

EyePoint Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

07/01/2026, 22:34

4 minutes to read